Cold Sore Fever Blister Treatment
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
55910-963 -
Package NDC
55910-963-07 -
Application number
ANDA208754 -
SPL ID
f2e98075-3b9a-4d4f-9d98-b37b0887f1f3 -
SPL set ID
4286c19b-8c81-40f6-8d97-cfebba87c174 -
UNII
9G1OE216XY -
RxCUI
797534
What the source publishes
- Labeler
- Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
- Active ingredients
- Docosanol
- Form
- CREAM
- Routes
- TOPICAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN OTC DRUG
- Prescription
- Non-prescription
Names this record is found by
Complete source data
{
"name": "Cold Sore Fever Blister Treatment",
"splId": "f2e98075-3b9a-4d4f-9d98-b37b0887f1f3",
"labels": [
{
"setId": "4286c19b-8c81-40f6-8d97-cfebba87c174",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4286c19b-8c81-40f6-8d97-cfebba87c174",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4286c19b-8c81-40f6-8d97-cfebba87c174"
}
],
"routes": [
"TOPICAL"
],
"labeler": "Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 TUBE in 1 PACKAGE (55910-963-07) / 2 g in 1 TUBE",
"package_ndc": "55910-963-07",
"identifierStatus": "well-formed",
"marketing_end_date": "20270215",
"marketing_start_date": "20220915"
}
],
"productId": "55910-963_f2e98075-3b9a-4d4f-9d98-b37b0887f1f3",
"useDomain": "unknown",
"dosageForm": "CREAM",
"productNdc": "55910-963",
"deaSchedule": null,
"genericName": "Docosanol",
"productType": "HUMAN OTC DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": "20270215",
"activeIngredients": [
{
"name": "DOCOSANOL",
"strength": "100 mg/g"
}
],
"applicationNumber": "ANDA208754",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220915",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "non-prescription",
"harmonizedIdentifiers": {
"upc": [
"0359726922081"
],
"unii": [
"9G1OE216XY"
],
"rxcui": [
"797534"
],
"spl_set_id": [
"4286c19b-8c81-40f6-8d97-cfebba87c174"
],
"manufacturer_name": [
"Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:55910-963_f2e98075-3b9a-4d4f-9d98-b37b0887f1f3"